[Effects of xinchuanling (XC-1) and its derivative XC-2 on adrenoceptors and arterial muscle].
D000818:Animals; D001011:Aorta; D002118:Calcium / Q000037:antagonists & inhibitors; D004372:Ducks; D005260:Female; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology*; D011817:Rabbits; D011869:Radioligand Assay; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D010879:Piperazines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D014665:Vasodilator Agents; C051415:4-amino-3,5-dichlorophenyl-4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazineethanol; C051416:2,6-dichloro-4-(2-(4-((2,3,4-trimethoxyphenyl)methyl)-1-piperazinyl)-1-((trimethylsilyl)oxy)ethyl)benzeneamine; D002118:Calcium